FDA Grants Priority Review to Sodium Thiosulfate for Ototoxicity Prevention |
The FDA granted priority review to the new drug application for sodium thiosulfate for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localized, non-metastatic, solid tumors.
|
Read more
|